Uncategorized
Johnson & Johnson Vision completes TearScience acquisition
Johnson & Johnson Vision’s acquisition of TearScience has been completed, according to a company press release.The company announced in August that it would acquire TearScience, which has FDA clearance for products to evaluate meibomian gland health and treat meibomian gland dysfunction, the leading cause of dry eye disease. Financial terms of the deal were not disclosed.